Bio-Techne (TECH) Asset Utilization Ratio (2010 - 2026)

Bio-Techne's (TECH) quarterly Asset Utilization Ratio came in at 0.48 in Q1 2026, up 4.93% year-on-year from 0.45 in Q1 2025, and down 0.87% quarter-over-quarter from 0.48 in Q4 2025.

Bio-Techne (TECH) Asset Utilization Ratio (2010 - 2026) Analysis & Trends

Bio-Techne's Asset Utilization Ratio history runs 17 years deep, the most recent figure standing at 0.48 for Q1 2026.

  • On a quarterly basis, Asset Utilization Ratio rose 4.93% year-over-year to 0.48 in Q1 2026; TTM through Mar 2026 was 0.48, a 4.93% increase from a year earlier, with the FY2025 full-year figure at 0.46, up 6.84% from the prior year.
  • Asset Utilization Ratio eased to 0.48 in Q1 2026 per TECH's latest filing, from 0.48 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.48 in Q4 2025 and bottomed at 0.33 in Q2 2023.
  • The 5-year median for Asset Utilization Ratio is 0.43 (2024), against an average of 0.43.
  • Across the five-year window, Asset Utilization Ratio slumped 31.05% in 2023 and gained 28.78% in 2024, its largest moves.
  • Year by year, Asset Utilization Ratio stood at 0.36 in 2022, then gained by 15.45% to 0.42 in 2023, then rose by 5.99% to 0.44 in 2024, then climbed by 8.83% to 0.48 in 2025, then declined by 0.87% to 0.48 in 2026.
  • Per Business Quant, the three latest TECH Asset Utilization Ratio figures stand at 0.48 (Q1 2026), 0.48 (Q4 2025), and 0.48 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.69
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.47
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.37
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Bio-Techne 11.23 Bn 11.02 Bn 208.29 Mn 0.48

Historic Data

Download Data
DateValue
Mar 31, 2026 0.48
Dec 31, 2025 0.48
Sep 30, 2025 0.48
Jun 30, 2025 0.47
Mar 31, 2025 0.45
Dec 31, 2024 0.44
Sep 30, 2024 0.43
Jun 30, 2024 0.43
Mar 31, 2024 0.42
Dec 31, 2023 0.42
Sep 30, 2023 0.42
Jun 30, 2023 0.33
Mar 31, 2023 0.34
Dec 31, 2022 0.36
Sep 30, 2022 0.37
Jun 30, 2022 0.48
Mar 31, 2022 0.47
Dec 31, 2021 0.45
Sep 30, 2021 0.43
Jun 30, 2021 0.43